Form 4: TFS Financial CORP Officer Cathy W. Zbanek Reports Stock Sale and Holdings
SEC Form 4 Filing
Cathy W. Zbanek, Chief Synergy Officer of TFS Financial CORP, reports the sale of 20,000 shares of common stock at $13.72 per share and discloses holdings of common stock, restricted stock units, performance share units, and employee stock options.
Summary
- On February 6, 2025, Cathy W. Zbanek, Chief Synergy Officer of TFS Financial CORP [TFSL], sold 20,000 shares of common stock at a price of $13.72 per share.
- Following the transaction, Zbanek directly owns 88,197 shares of common stock.
- Zbanek also indirectly owns 13,264 shares through an ESOP and 5,330 shares through a 401(k).
- The report details Zbanek's holdings of various derivative securities, including restricted stock units (RSUs), performance share units (PSUs), and employee stock options.
- These derivative securities represent the right to acquire shares of TFS Financial Corporation common stock.
- The RSUs vest in installments, typically annually, and are entitled to dividend equivalent rights.
- The PSUs are contingent on performance results and also carry dividend equivalent rights.
- Zbanek holds options to purchase a total of 424,400 shares at prices ranging from $14.74 to $19.31, vesting at various dates.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of stock transactions by an officer. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders. It provides transparency into the transactions and holdings of company executives, which can be of interest to investors.
Stakeholder Impact
- The sale of shares by an officer may be perceived differently by stakeholders.
- Some may view it as a lack of confidence in the company, while others may see it as a normal part of personal financial planning.
Key Dates
| Date | Description |
|---|---|
| 05/28/2015 | Grant date of 108,300 stock options at $14.81, vesting in five equal annual installments beginning May 28, 2016. |
| 12/15/2015 | Grant date of 49,200 stock options at $19.06, vesting in three equal annual installments beginning December 10, 2016. |
| 12/15/2016 | Grant date of 79,400 stock options at $19.31, vesting in three equal annual installments beginning December 10, 2017. |
| 01/05/2018 | Grant date of 187,500 stock options at $14.74, vesting in three equal annual installments beginning December 10, 2018. |
| 12/15/2022 | Grant date of 14,000 Restricted Stock Units (RSUs), vesting in three equal annual installments beginning December 10, 2023. |
| 12/15/2022 | Grant date of 21,000 Performance Share Units (PSUs) dependent on performance results during the two fiscal year period ended September 30, 2024. |
| 03/04/2024 | Grant date of 14,200 Restricted Stock Units (RSUs), vesting in three equal annual installments beginning December 10, 2024. |
| 09/30/2024 | End of the two fiscal year period for performance determination of the December 15, 2022 Performance Share Units (PSUs). |
| 11/21/2024 | Performance level of 90.0% achieved on a target award of 21,000 Performance Share Units (PSUs), resulting in a total earned award of 18,990 shares. |
| 12/19/2024 | Grant date of 15,900 Restricted Stock Units (RSUs), vesting in three equal annual installments beginning December 10, 2025. |
| 02/06/2025 | Date of the transaction where 20,000 shares of common stock were sold at $13.72 per share. |
| 05/28/2025 | Expiration date of employee stock options. |
| 12/17/2025 | Expiration date of employee stock options. |
| 12/15/2026 | Expiration date of employee stock options. |
| 01/05/2028 | Expiration date of employee stock options. |
Keywords
Form 4, TFS Financial CORP, TFSL, Insider Trading, Stock Sale, Cathy W. Zbanek, Chief Synergy Officer, Restricted Stock Units, Performance Share Units, Stock Options, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.